EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 148 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.35 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $350,760 | +10.6% | 12,000 | 0.0% | 0.00% | – |
Q3 2022 | $317,040 | -91.1% | 12,000 | -85.9% | 0.00% | -100.0% |
Q1 2021 | $3,554,000 | -55.7% | 85,141 | -50.5% | 0.00% | -50.0% |
Q4 2020 | $8,018,000 | +2.9% | 172,174 | -6.1% | 0.00% | 0.0% |
Q3 2020 | $7,792,000 | -25.8% | 183,420 | -16.2% | 0.00% | -33.3% |
Q2 2020 | $10,505,000 | +2.1% | 218,937 | -2.1% | 0.00% | -25.0% |
Q1 2020 | $10,292,000 | -31.0% | 223,737 | -9.8% | 0.00% | 0.0% |
Q4 2019 | $14,911,000 | +6.2% | 248,179 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $14,039,000 | +1.6% | 248,179 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $13,819,000 | +10.3% | 248,179 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $12,531,000 | +14.5% | 248,179 | -8.7% | 0.00% | 0.0% |
Q4 2018 | $10,948,000 | -9.9% | 271,747 | +55.1% | 0.00% | 0.0% |
Q3 2018 | $12,146,000 | +7.2% | 175,201 | +17.0% | 0.00% | 0.0% |
Q2 2018 | $11,335,000 | +136.1% | 149,808 | +64.4% | 0.00% | +100.0% |
Q1 2018 | $4,801,000 | -1.4% | 91,117 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $4,867,000 | +12.2% | 91,117 | +25.3% | 0.00% | 0.0% |
Q3 2017 | $4,337,000 | -59.9% | 72,713 | -47.0% | 0.00% | -50.0% |
Q2 2017 | $10,814,000 | +12.8% | 137,077 | +18.6% | 0.00% | 0.0% |
Q1 2017 | $9,589,000 | +70.2% | 115,614 | +62.8% | 0.00% | +100.0% |
Q4 2016 | $5,634,000 | +18.7% | 71,008 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $4,747,000 | – | 71,008 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 112,666 | $1,777 | 0.65% |
Smith, Graham & Co., Investment Advisors, LP | 273,099 | $4,306,771 | 0.54% |
BRANDES INVESTMENT PARTNERS, LP | 1,134,363 | $17,888,904 | 0.35% |
TANG CAPITAL MANAGEMENT LLC | 118,857 | $1,874,375 | 0.26% |
Virtus Investment Advisers, Inc. | 20,867 | $329,073 | 0.22% |
DENALI ADVISORS LLC | 32,300 | $509,371 | 0.18% |
Nebula Research & Development LLC | 11,473 | $180,929 | 0.10% |
SCOUT INVESTMENTS, INC. | 131,192 | $1,995,430 | 0.05% |
XTX Topco Ltd | 15,050 | $237,339 | 0.04% |
PDT Partners, LLC | 19,745 | $311,379 | 0.04% |